News

Panelist says insights into the needs of particular populations of patients can help.

Members of a panel discussion on market access at Asembia’s specialty pharmacy meeting shared advise and insights into how best win acceptance and improve uptake of new products.

George Van Antwerp, pharmacy and PBM leader of Deloitte, presents at the Asembia 2021 Specialty Pharmacy Summit and shares framework of specialty pharmacy.

Steve Peskin of Horizon BCBS of NJ, executive medical director of Population Health at Horizon Blue Cross Blue Shield of New Jersey, shares forms of value-based contracting between payers and pharmaceutical companies.

Dana Erickson, a senior vice president, is moving into the top job at the Blues plan after Craig Samitt, M.D., unexpectedly resigned earlier this year.

Lance Grady, head of Market Access at Avalere Health, gives a preview of his presentation he gives at Asembia and discusses the significant changes made to specialty pharmacy because of the COVID-19 public health emergency.

Pharma industry experts Adam Fein, Ph.D., and Doug Long, MBA, described the growth of specialty pharmacy and the competition for that part of the pharma market during the opening presentation today at the Asembia 2021 Specialty Pharmacy Summit in Las Vegas.

If payers have timely access to accurate network data, they can manage costs, improve engagement with providers and help members make healthcare choices.

Andrew Toy, M.S., president, chief technology officer and board member at Clover Health, is one of the emerging health leaders featured in the October 2021 issue of Managed Healthcare Executive. In this video he talks about the career achievement that has given him the greatest satisfaction and who has had the greatest influence in his life.

Toy is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.

Evie Powell, Ph.D., virtual reality architect at Proprio, is one of the emerging health leaders featured in the October 2021 issue of Managed Healthcare Executive. In this video she talks about the career achievement that has given her the greatest satisfaction and who has had the greatest influence in her life, which is her Ph.D. adviser and a professor at North Carolina State University, Tiffany Barnes.

Evie Powell is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.

Recently approved for children 6 to 11 years, Dupixent reduces severe asthma attacks and improves lung function.

The key to efficiency under value-based care models is a strategic approach to risk stratification.

In COVID-19 news, the FDA issues EUA for both Moderna’s and J&J’s COVID-19 booster. In new drug approvals, there is a novel therapy for macular degeneration, new therapies for eye disease and opioid overdose, as well as new therapies for asthma and HIV in children.

Disparities, biosimilars and digital therapeutics were among the featured topics at the meeting in Denver that had 1,900 attendees.

Michael Palantoni, vice president of platform services at Athenahealth, is one of the emerging health leaders featured in the October 2021 issue of Managed Healthcare Executive. In this video he talks about the career achievement that has given him the greatest satisfaction and who has had the greatest influence in his life, which is his wife.

Michael Palantoni is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.

Brenden O'Hara, clinical pharmacist of Blue Cross Blue Shield of North Carolina, discusses innovations in diabetes management and what’s to come in 2022 at AMCP Nexus 2021.

Juday, director of specialty product development at CVS Health, shares how CBT’s for insomnia can save payers and can yield cost savings with or without a digital component.

Consultant Jeffrey Casberg says biosimilars are coming on strong and that interchangeability may not be much for the products dispensed through specialty pharmacies because specialty pharmacies are often in frequent touch with physicians.

Page and Taddei-Allen of WellDyne discuss precision medicine and its implications for pharmacy management at this year's AMCP Nexus Conference

Melissa Andel, principal of CommonHealth Solutions, discusses Medicare Part D in the future — more particularly in the next year — and why these changes are being made during this year's AMCP Nexus conference.

Shantanu Nundy, M.D., MBA, chief medical officer at Accolade, is one of the emerging health leaders featured in the October 2021 issue of Managed Healthcare Executive. In this video he talks about the career achievement that has given him the greatest satisfaction and who has had the greatest influence in his life, which are his parents, sister and aunt and uncle.

Shantanu Nundy is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.

A panel discussion on prescription digital therapeutics identified them as a sweet spot for value-based agreements and collection of real-world evidence. But should they be paid for through the pharmacy benefit? And is there enough evidence available for payers and PBMs to make sound coverage and formulary decisions? For answers, stay tuned.

Joan Barrett of Axene Health Partners and Nicole Bulochnik of Optum discuss value-based care models and actuaries' involvement during this year's AMCP Nexus conference.

Christina Barrington, VP of pharmacy programs at Priority Health, spoke at AMCP Nexus 2021 about the value of managed care, real-world evidence and more.

Melissa Hanna, J.D., MBA, co-founder and CEO of Mahmee in Los Angeles, is one of the emerging health leaders featured in the October 2021 issue of Managed Healthcare Executive. In this video she talks about the career achievement that has given her the greatest satisfaction and who has had the greatest influence on her life, which is her mother.

Melissa Hanna is one of 13 up-and-coming health leaders featured in this annual Managed Healthcare Executive series.